Avivagen Stock Price, News & Analysis
Company Description
Avivagen (OTC Link: VIVXF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $7.8K.
VIVXF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of VIVXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Avivagen (VIVXF) stock last traded at $0.0000. At a market capitalization of $7.8K, VIVXF is classified as a micro-cap stock with approximately 77.7M shares outstanding.
Latest News
Avivagen has 10 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings. View all VIVXF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Avivagen (VIVXF) currently stands at 1.9 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Avivagen (VIVXF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 105.6 to 1000.0 days.
VIVXF Company Profile & Sector Positioning
Avivagen (VIVXF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing VIVXF often look at related companies in the same sector, including Bloomios Inc (BLMS), Onassis Holdings Corp (ONSS), Item 9 Labs (INLB), Emergent Health (EMGE), and Halo Collective Inc (HCANF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VIVXF's relative position within its industry.